RhoGAM®

RhoGAM® Brand was the first and is still the leading* Rho(D) immune globulin brand for the prevention of Rh hemolytic disease of the newborn (HDN).

Prior to the introduction of RhoGAM® Brand in 1968, HDN was a major cause of infant mortality, responsible for an average of 10,000 deaths annually in the United States.3 Since the introduction of Rh immune globulin products, like RhoGAM® Brand, the incidence of HDN has been virtually eliminated in most developed countries. RhoGAM® Brand is made by Ortho Clinical Diagnostics, a Johnson & Johnson company.